cytidine has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, ES; Davis, IC; Rosas, LE; Yaxley, PE; Young, AA | 1 |
| Bryan, JN; Flesner, BK; Kumar, SR | 1 |
| Bonney, PL; Dhawan, D; Fourez, LM; Fulkerson, CM; Jones, DR; Jones, PA; Klaunig, JE; Knapp, DW; Marquez, VE; Wang, Z; Wu, Q | 1 |
1 trial(s) available for cytidine and Canine Diseases
| Article | Year |
|---|---|
Impact of cytidine diphosphocholine on oxygenation in client-owned dogs with aspiration pneumonia.
Topics: Animals; Cytidine; Cytidine Diphosphate Choline; Dog Diseases; Dogs; Hypoxia; Lung; Oxygen; Pneumonia, Aspiration; Respiratory Distress Syndrome; Saline Solution | 2022 |
2 other study(ies) available for cytidine and Canine Diseases
| Article | Year |
|---|---|
6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cytidine; DNA-Cytosine Methylases; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Down-Regulation; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Thioguanine | 2014 |
Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs.
Topics: Administration, Oral; Aldehyde Oxidase; Animals; Chromatography, High Pressure Liquid; Cytidine; Cytosol; DNA Methylation; Dog Diseases; Dogs; Female; Half-Life; Indiana; Liver; Macrolides; Male; Neoplasms; Neutropenia; Schools, Veterinary | 2017 |